— Know what they know.
Not Investment Advice

EAH.L LSE

ECO Animal Health Group plc
1W: -0.3% 1M: -0.3% 3M: +5.0% YTD: -9.1% 1Y: +33.6% 3Y: -9.9% 5Y: -68.2%
£98.19 ($1.30)
+0.19 (+0.19%)
 
Weekly Expected Move ±4.4%
£90 £94 £98 £102 £107
LSE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 61 · £65.4M mcap · 59M float · 0.229% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap£65.4M ($0.9M)
52W Range77.1-116.9
Volume25,323
Avg Volume135,823
Beta0.70
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEODavid Charles Hallas
Employees213
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date1995-09-26
The Grange
London, LO N14 6BN
GB
44 20 8336 2900
About ECO Animal Health Group plc

ECO Animal Health Group plc, established in 1972 and based in New Malden, United Kingdom, focuses on the worldwide research, regulatory approval, and distribution of veterinary pharmaceutical solutions. The company's offerings include Aivlosin, a macrolide antibiotic specifically formulated to address digestive and respiratory illnesses in pigs and poultry. Additionally, its product range encompasses various generic drugs like Ecomectin, Ecoheart, Ecotraz, and Ecomintic. These endectocides and other antiparasitics are designed to manage and prevent parasitic infestations such as worms, ticks, and lice across a diverse array of animals, including cattle, sheep, pigs, horses, and dogs. ECO Animal Health Group also provides Chlortetracycline and Oxytetracycline for treating bacterial infections in swine, fowl, and bovine animals.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms